ADAP - Wall Street Estimates - Adaptimmune Therapeutics plc

Healthcare - Biotechnology - NASDAQ - GB

$ 0.5799

-1.71 %

$ 148 M

Market Cap

-3.41

P/E

Price Target Average

380.69%

Revenue Forecast Estimate

57.62%

EBIT Estimate

--19.58%

Net Income Estimate

46.99%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Adaptimmune Therapeutics plc

Wall Street analysts predict an average 1-year price target for ADAP of $2.79 , with forecasts ranging from a low of $1 to a high of $4 .

ADAP Lowest Price Target Wall Street Target

1 USD 72.44%

ADAP Average Price Target Wall Street Target

2.79 USD 380.69%

ADAP Highest Price Target Wall Street Target

4 USD 589.77%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free